Retatrutide is an investigational medication designed to treat obesity and type 2 diabetes. It is a multi-receptor agonist, targeting GLP-1, GIP, and glucagon receptors, which helps regulate blood sugar levels, suppress appetite, and promote weight loss. Retatrutide has shown promise in clinical trials for its ability to significantly reduce body weight and improve metabolic health.
Description
Additional information
Weight |
N/A |
---|---|
mg |
5mg , 10mg |
Test Report